Navigation Links
Ampio Provides Progress Report on Clinical Programs in Preparation for Annual Shareholders Meeting
Date:11/14/2012

orbid premature ejaculation and erectile dysfunction (ED).

  • Ampio has completed two phase 3 clinical trials in Europe on Zertane™.
  • Ampio is poised to file an IND for pivotal trials under the 505(b)2 pathway in the USA adhering to the guidance provided by the FDA during our Pre-IND meeting.
  • Ampio has identified sites to conduct its pivotal trials in the USA.
  • Ampio will be filing for approval of Zertane™, based on the European trials results, in Australia (TGA). Approval in Australia will facilitate approval in many countries in Latin America and the Pacific Rim where we have already licensed Zertane™.
  • Ampio has secured a manufacturing agreement with Ethypharm (France) to produce the ODT formulation of Zertane™, which will be used for the pivotal trials in the USA.
  • Ampio entered into a contract with Syngene (Bangalore, India) to manufacture Zertane ED™, which will be used in clinical trials in South Korea, in compliance with FDA standards, by its partner/licensee Daewoong.
  • Ampio was awarded multiple US and international patents on Zertane™ and was recently awarded patents on the combination treatment for PE and ED (as well as patents for the reduction of potential side effects of tramadol) in China, Europe and multiple other countries.
  • Ampio has secured licenses in Brazil and S. Korea for these drugs and is currently in discussions with potential global partners.
  • Ampio has contracted Pharmerit, Inc. (Cambridge, MA) to complete the development of the Patient Outcome for Premature Ejaculation (POPE) patient reported outcome (PRO) tool for the evaluation of premature ejaculation therapy. When completed in the next few weeks this will be the only validated PRO tool for PE in the FDA environment.  The completion of the POPE trial will allow Ampio to file the IND in the USA and conclude its negotiations with phar
    '/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novation Champions Reusable Packaging for Sustainability in Healthcare
2. Daiichi Sankyo ha completato larruolamento dei pazienti per lo studio Hokusai-VTE su Edoxaban, il più ampio trial clinico di fase 3 per il trattamento delle tromboembolie venose ricorrenti
3. Champions Oncology Reports Financial Results for the Quarter Ended July 31, 2012
4. Terso Solutions partners with Champion Medical Technologies to offer fully automated tracking of Tissue and Implantable Devices
5. Champions Oncology to Present at Rodman & Renshaw Conference
6. Champions Oncology Reports Resignation Of Director
7. eCardio Supports the Carolinas HealthCare Foundation Through Grant for Heart Of A Champion Day
8. Ampio Pharmaceuticals Announces Closing of Public Offering
9. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
10. Ampio Pharmaceuticals Announces Exercise of Over-Allotment Option
11. Ampio Pharmaceuticals Announces Pricing of Public Offering of 4,615,400 Shares of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... Calif. , April 30, 2015  Accuray ... it has signed an agreement with MIM Software ... the TomoTherapy ® and CyberKnife ® product ... Accuray and MIM technology. This is Accuray,s second ... the development of the first iPad-based treatment plan ...
(Date:4/30/2015)... April 30, 2015  Thoratec Corporation (NASDAQ: THOR ... to save, support and restore failing hearts, said today ... Lynch 2015 Healthcare Conference on Thursday, May 14. ... Executive Officer, will provide an update on the company, ... Eastern Daylight Time). The presentation will be ...
(Date:4/30/2015)... Calif., April 30, 2015  DURECT Corporation (Nasdaq: ... quarter of 2015.  Total revenues were $4.8 million and ... ended March 31, 2015 as compared to total revenues ... for the three months ended March 31, 2014.At March ... million, compared to cash and investments of $34.9 million ...
Breaking Medicine Technology:Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 2Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 3Thoratec Presentation At Bank Of America Merrill Lynch Healthcare Conference To Be Webcast 2DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 2DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 3DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 4DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 5DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 6DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 7DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 8DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 9
... 2011 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... Application (NDA) to the U.S. Food and Drug Administration (FDA) ... October 2010.  The Company believes this is a Class 2 ... for the rapid treatment of agitation in schizophrenia or bipolar ...
... For manufacturers who must comply with current Good Manufacturing ... be time consuming and difficult. This task is considerably ... each with their own GMP requirements. PharmOut, ... an online database of GMP guidelines. This database, available ...
Cached Medicine Technology:Alexza Announces Resubmission of AZ-004 (Staccato® Loxapine) NDA 2Alexza Announces Resubmission of AZ-004 (Staccato® Loxapine) NDA 3Global GMP Guidelines Available in Online GMP Library 2
(Date:5/1/2015)... BWI (PRWEB) May 02, 2015 The ... It is http://www.thevenetiangracebay.com , and it is elegant ... the stunning white and attractive turquoise hues of Grace ... Google, sixty seven percent of leisure travelers used their ... that smartphones were used in the planning and researching ...
(Date:5/1/2015)... Jusuru International has been awarded the prestigious ... its flagship nutritional supplement, Liquid BioCell™ Life, and the ... new logo, new packaging, new products, and new messaging. ... identify and promote programs that serve as examples of ... Jusuru International for their outstanding accomplishments and contributions to ...
(Date:5/1/2015)... 01, 2015 The Workgroup for ... authority on the use of health IT to create ... contributing resource to the United States Government Accountability Office ... readable cards in Medicare. The report, “ Potential Uses ... was released to the public on Apr. 24, 2015 ...
(Date:5/1/2015)... It’s raining bills on Capitol Hill with members in both ... for telemedicine. , “Such action is unprecedented in ... said Jonathan Linkous, CEO of the American Telemedicine Association (ATA). ... embrace the use of telecommunications in the delivery of care. ... to improve quality, access, equity and affordability of healthcare.”, ...
(Date:5/1/2015)... Ernst & Young (EY) has announced Melanie Rosenthal, ... and Burak Sezen, Co-Founder & CTO of RowdMap, Inc. ... The Year® 2015 Awards in the Ohio Valley Region ... leader in assurance, tax, transaction and advisory services and ... audit companies in the world. The awards program recognizes ...
Breaking Medicine News(10 mins):Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2
... shows screening newborns for biochemical genetic disorders may improve ... researchers say false-positive screening results may increase stress levels ... required a separate test, but now, doctors can screen ... sample of blood by using a device called the ...
... is a joyous experience. But if the experience does not ... the woman. Researchers conducted a study to obtain the views ... the second stage of labor. ,A new study ... the delivery of their child may happen. Researchers say women ...
... women who change partners between the births of their first two ... birth weight than women who have the same partner.// ... the first year of life. The results are the same even ... interval between births, and the decades of birth. ...
... announced what it calls the second heart-related death in ... for a government //investigation into the safety of that ... ,The Physicians Committee for Responsible Medicine states that a ... cardiac arrest while on the Atkins diet. The group ...
... study shows a novel new drug is beneficial for ... and is the first in a new class of ... drug is called cytotoxic T-lymphocyte-associated antigen 4-IgG1 or CTLA4Ig. ... treatment of rheumatoid arthritis. Researchers from Belgium conducted a ...
... It's called partial-breast irradiation, and proponents see it as ... just had a lumpectomy.// ,Thousands of women ... one week or less of radiation after breast cancer ... required for whole-breast irradiation. ,But its long-term benefits ...
Cached Medicine News:Health News:Screening Newborns Questioned 2Health News:Changing Partners may put Expectant Mothers at Risk 2Health News:Partial-Breast Irradiation an Unproven Therapy 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: